CSI Market
Sign In | Register

Lakeshore Biopharma Co Ltd (LSB) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access LSB Annual Cash Flow →
The data below summarizes Lakeshore Biopharma Co Ltd's cash flow activity from Mar 31 2023 to Mar 31 2024, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2024)
12 Months 		0 0 0 (Mar 31 2023)
Operating Activities
Income-61.09
Depreciation & amortization4.99
Amortization of Other Assets0.96
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Long-Lived Assets to be Disposed of11.31
Provision For Loan Losses Expensed0.70
Inventories Decrease /-Increase-2.54
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation1.38
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants-0.63
Non Cash Lease Expense-
Increase Decrease In Deferred Government Grants-
Increase Decrease In Operating Lease Liability-
Income taxes-3.06
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable1.96
Increase (Decrease) in Accounts Payable-1.79
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities7.50
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.75
Other Working Capital0.00
Other Noncash Expense0.67
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.51
Discontinued operations0.00
Net Cash flow from Operating Activities-41.61
Investing Activities
Capital Expenditures-6.24
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-6.24
Financing Activities
Short-term debt Net-58.74
Other borrowing transactions0.00
Long-term debt - borrowings47.62
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock40.06
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-52.20
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Proceeds From Business Combination-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities28.93
Effect of exchange rate on cash flow1.47
Discontinued operations0.00
Free Cash Flow-47.85
Total Cash Flow-17.45
4 historic quarters locked

Sign in to unlock the full Lakeshore Biopharma Co Ltd cash flow history.

Sign In Create Free Account

About Lakeshore Biopharma Co Ltd Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-25-069880

Figures are derived from filed reports and may be restated. Historical data is subject to revision.